Leo Pharma says it’s turned a profit for the first time in seven yearsnews2026-02-18T08:00:28+00:00February 18th, 2026|Endpoints News|
Moderna faces setback in Arbutus’ mRNA patent fightnews2026-02-17T20:36:05+00:00February 17th, 2026|Endpoints News|
Ocular Therapeutix’ Axpaxli shows superiority over Eylea, shares sinknews2026-02-17T12:05:11+00:00February 17th, 2026|Endpoints News|
Gilead gets cancer drug from China-based Genhouse for $80M upfrontnews2026-02-13T18:53:40+00:00February 13th, 2026|Endpoints News|
Pentagon adds, then withdraws, WuXi AppTec to Chinese military listnews2026-02-13T18:48:38+00:00February 13th, 2026|Endpoints News|
Lilly appeals retatrutide classification ruling in case that could impact compoundersnews2026-02-13T17:31:04+00:00February 13th, 2026|Endpoints News|
Moderna’s flu shot dilemma muddies 2028 break-even guidancenews2026-02-13T15:55:13+00:00February 13th, 2026|Endpoints News|
Lilly stockpiles $1.5B worth of weight loss pill ahead of US approvalnews2026-02-13T15:00:35+00:00February 13th, 2026|Endpoints News|
PTC Therapeutics withdraws US filing for troubled Duchenne treatment Translarnanews2026-02-13T11:42:19+00:00February 13th, 2026|Endpoints News|
Icon’s stock drops 40% after disclosing internal accounting probenews2026-02-12T20:30:10+00:00February 12th, 2026|Endpoints News|
